BP’s Insulet PODD Stock Holding History

BP’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,743	Closed	-$478K	–	409
2021 Q2	$478K	Hold	1,743	–	–	0.02%	425
2021 Q1	$454K	Buy	+1,743	New	+$467K	0.02%	497

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

DCP

D1 Capital Partners New York $34.8B AUM 11.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BP's PODD Position: Q3 2021 in Review

BP sold out of Insulet (PODD) in Q3 2021, closing a stake of 1,743 shares — an estimated $478K sold.

BP first reported a position in PODD in Q1 2021 and held it in 2 quarters. The position peaked at $478K in Q2 2021. 433 funds tracked by Wall St. Rank hold PODD as of Q3 2021.

BP reported no remaining Insulet position as of Q3 2021 after selling out during the quarter.
BP sold 1,743 Insulet shares in Q3 2021, an estimated $478K.
BP first reported a position in Insulet in Q1 2021 and held it in 2 quarters.
BP's Insulet position peaked at $478K in Q2 2021.
433 funds tracked by Wall St. Rank held Insulet as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.